🇺🇸 FDA

Drug profile · INN

atomoxetine hydrochloride

ATOMOXETINE HYDROCHLORIDE

approved
US status
approved
Patents linked
3
News articles
0

Quick answer

atomoxetine hydrochloride (ATOMOXETINE HYDROCHLORIDE) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN atomoxetine hydrochloride
Brand ATOMOXETINE HYDROCHLORIDE
Route ORAL
Formulation CAPSULE
Originator Teva Pharma GmbH

Related patents

Search patents →

  1. US 7569729

    Stable atomoxetine hydrochloride, a process for the preparation thereof, and an analytical control of its stability

    Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7507861

    Process for the preparation of atomoxetine hydrochloride

    Expires Mon Mar 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7439399

    Processes for the preparation of atomoxetine hydrochloride

    Expires Mon Oct 16 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is atomoxetine hydrochloride?

atomoxetine hydrochloride (ATOMOXETINE HYDROCHLORIDE) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for atomoxetine hydrochloride?

ATOMOXETINE HYDROCHLORIDE is a marketed brand name for atomoxetine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of atomoxetine hydrochloride?

atomoxetine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.